Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Multiple Sclerosis

  Free Subscription


30.12.2018

2 AJNR Am J Neuroradiol
1 BMC Neurol
1 Int J Neurosci
1 J Neuroimmunol
2 J Neurol
1 J Neurol Sci
2 Neurol Clin Pract
2 Neurology
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJNR Am J Neuroradiol

  1. SCHOONHEIM MM, Geurts JJG
    What Causes Deep Gray Matter Atrophy in Multiple Sclerosis?
    AJNR Am J Neuroradiol. 2018 Dec 27. pii: ajnr.A5942. doi: 10.3174/ajnr.A5942.
    PubMed     Text format    

  2. PONTILLO G, Cocozza S, Lanzillo R, Russo C, et al
    Determinants of Deep Gray Matter Atrophy in Multiple Sclerosis: A Multimodal MRI Study.
    AJNR Am J Neuroradiol. 2018 Dec 20. pii: ajnr.A5915. doi: 10.3174/ajnr.A5915.
    PubMed     Text format     Abstract available


    BMC Neurol

  3. MATIAS-GUIU JA, Cortes-Martinez A, Montero P, Pytel V, et al
    Structural MRI correlates of PASAT performance in multiple sclerosis.
    BMC Neurol. 2018;18:214.
    PubMed     Text format     Abstract available


    Int J Neurosci

  4. SHAHEEN HA, Sayed SS, Daker LI, AbdelAziz HE, et al
    Does vitamin D deficiency predict early conversion of clinically isolated syndrome? A preliminary Egyptian study.
    Int J Neurosci. 2018;128:946-951.
    PubMed     Text format     Abstract available


    J Neuroimmunol

  5. MEHTA D, Wani S, Wallace L, Henders AK, et al
    Cumulative influence of parity-related genomic changes in multiple sclerosis.
    J Neuroimmunol. 2018;328:38-49.
    PubMed     Text format     Abstract available


    J Neurol

  6. BRAUNE S, Grimm S, van Hovell P, Freudensprung U, et al
    Comparative effectiveness of delayed-release dimethyl fumarate versus interferon, glatiramer acetate, teriflunomide, or fingolimod: results from the German NeuroTransData registry.
    J Neurol. 2018;265:2980-2992.
    PubMed     Text format     Abstract available

  7. SONG J, Westerlind H, McKay KA, Almqvist C, et al
    Familial risk of early- and late-onset multiple sclerosis: a Swedish nationwide study.
    J Neurol. 2018 Dec 21. pii: 10.1007/s00415-018-9163.
    PubMed     Text format     Abstract available


    J Neurol Sci

  8. ZACHARZEWSKA-GONDEK A, Pokryszko-Dragan A, Gondek TM, Koltowska A, et al
    Apparent diffusion coefficient measurements in normal appearing white matter may support the differential diagnosis between multiple sclerosis lesions and other white matter hyperintensities.
    J Neurol Sci. 2018;397:24-30.
    PubMed     Text format     Abstract available


    Neurol Clin Pract

  9. NOVO AM, Batista S, Alves C, d'Almeida OC, et al
    The neural basis of fatigue in multiple sclerosis: A multimodal MRI approach.
    Neurol Clin Pract. 2018;8:492-500.
    PubMed     Text format     Abstract available

  10. FITZGERALD KC, Salter A, Tyry T, Fox RJ, et al
    Pseudobulbar affect: Prevalence and association with symptoms in multiple sclerosis.
    Neurol Clin Pract. 2018;8:472-481.
    PubMed     Text format     Abstract available


    Neurology

  11. PAPPOLLA A, Midaglia L, Boix Rodriguez CP, Puig AA, et al
    Simultaneous CMV and Listeria infection following alemtuzumab treatment for multiple sclerosis.
    Neurology. 2018 Dec 26. pii: WNL.0000000000006801.
    PubMed     Text format    

  12. GASPERINI C, Prosperini L, Tintore M, Sormani MP, et al
    Unraveling treatment response in multiple sclerosis: A clinical and MRI challenge.
    Neurology. 2018 Dec 26. pii: WNL.0000000000006810.
    PubMed     Text format     Abstract available


    PLoS One

  13. KOSKIMAKI F, Bernard J, Yong J, Arndt N, et al
    Gray matter atrophy in multiple sclerosis despite clinical and lesion stability during natalizumab treatment.
    PLoS One. 2018;13:e0209326.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: